Introduction: Cardiac myxoma is a benign and rare tumor, which can present with a grim phenomenon if the presentation is late or the diagnosis and surgery are delayed. The purpose of this study was to share our institutional experience of cardiac myxoma. Material and Methods: This retrospective study was conducted to evaluate patients undergoing procedures at a single tertiary care centre for t...

Myxoma jantung merupakan tumor jinak primer yang paling umum, biasanya ada di atrium kiri dengan titik perlekatan daerah fossa ovalis. Modalitas pencitraan untuk diagnosis myxoma antaranya ekokardiografi, computed tomography (CT), magnetic resonance imaging (MRI). Cardiac is the most common primary benign heart tumor, usually in left with an attachment point ovalis area. Many modalities for car...

PURPOSE Cardiac myxomas are rare benign tumors of the heart. Although most cases are sporadic, rare familial occurrence has been described. The aim of this study was to evaluate tumor involvement in family members of patients with cardiac myxoma and to compare familial vs nonfamilial cardiac myxoma in relation to age, sex, site and multichamber involvement, endocrine abnormality, embolism, pres...

Cardiac myxoma is usually a benign tumor in the left atrium that accounts for more than 50% of primary cardiac tumors. A 55-year-old female referred to our hospital with chest pain, referred pain to the left hand, and severe dyspnea. Transthoracic Doppler Echocardiography was performed and the results showed a large and mobile left atrial mass without any attachment to the interatrial septum. I...

conclusions the authors emphasize on the rarity of this pathology among children, its clinical polymorphism, the necessity of a rapid diagnosis, and an appropriate treatment to avoid complications and recurrence of the tumor. introduction right atrial myxoma is a rare disease among children and its clinical presentation is not specific. case presentation we reported a four-year-old girl with ex...

Myxoma may cause systemic embolization and frequently presents as ischemic stroke. There has been debates whether it is safe to use recombinant tissue plasminogen activator (rt-PA) in patients with cardiac myxoma who are presented with ischemic stroke at emergency department. we describe a young case of atrial myxoma with initial presentation of acute cerebral infarction symptoms who was treate...

Cardiac myxoma is the most common type of human heart tumor, yet the molecular mechanism is still poorly understood. In the present study, we found that the level of myocyte enhancer factor 2D (MEF2D), a key regulatory protein for cardiac development, was elevated in specimens of cardiac myxoma, and was positively associated with the proliferation of myxoma cells. MEF2D suppression reduced the ...